Skip to Main Content

Paper Details

Pancreatic cancer is associated with medication changes prior to clinical diagnosis.
Nat Commun
1
2023
PDAC, Pancreatic cancer, Patients, digestive system cancers, pancreatic cancer, pancreatic ductal adenocarcinoma, participants, person
Author NameAffiliation
Meir J StampferHarvard T. H. Chan School of Public Health
Meir J StampferHarvard T. H. Chan School of Public Health
Meir J StampferBrigham and Women's Hospital and Harvard Medical School
Meir J StampferHarvard T. H. Chan School of Public Health
Meir J StampferBrigham and Women's Hospital and Harvard Medical School
Meir J StampferHarvard T. H. Chan School of Public Health
Edward L GiovannucciHarvard T. H. Chan School of Public Health
Edward L GiovannucciHarvard T. H. Chan School of Public Health
Edward L GiovannucciHarvard T. H. Chan School of Public Health
Edward L GiovannucciHarvard T. H. Chan School of Public Health
Chris SanderDana-Farber Cancer Institute
Chris SanderBroad Institute of Harvard and MIT
Chris SanderHarvard Medical School
Chris SanderDana-Farber Cancer Institute
Chris SanderHarvard Medical School
Chris SanderBroad Institute of Harvard and MIT
Peter KraftHarvard T. H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T. H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
  • 1 - 20

Datasets